Immunitor Overview

  • Founded
  • 2000

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Immunitor General Information

Description

Manufacturer and developer of immunotherapies and therapeutic vaccines intended for tuberculosis. The company is engaged in the development and manufacturing of oral vaccines for human immunodeficiency virus, hepatitis B and C, influenza, tuberculosis, broad-spectrum bacterial, cancer, obesity and fungal infections, enabling its clients to avail immunotherapies for a number of serious diseases affecting the world.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Immune Network
Primary Office
  • 2906 West Broadway
  • Suite 365
  • Vancouver, British Columbia
  • Canada
+1 (360) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunitor Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Immunitor‘s full profile, request access.

Request a free trial

Immunitor Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer and developer of immunotherapies and therapeutic vaccines intended for tuberculosis. The company is engaged
Pharmaceuticals
Vancouver, Canada
0.000 0000-00-00
000000&0

000000

um dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
0000000000000
Pasadena, CA
000 As of 0000
00.000
000000 - 000 00.000

000000

ation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderi
0000 000000000
San Diego, CA
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Immunitor Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arrowhead Pharmaceuticals Corporation Pasadena, CA 000 00.000 000000 - 000 00.000
0000000 0000000000 Formerly VC-backed San Diego, CA 00 00000 000000000 00000
You’re viewing 2 of 2 competitors. Get the full list »

Immunitor Patents

Immunitor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2952042-A1 Oral composition and methods for immunotherapy Pending 13-Jun-2014 00000000000
US-20170106068-A1 Oral composition and methods for immunotherapy Abandoned 13-Jun-2014 00000000000
EP-3154577-A4 Oral composition and methods for immunotherapy Pending 13-Jun-2014 00000000000 0
EP-3154577-A1 Oral composition and methods for immunotherapy Pending 13-Jun-2014 00000000000
US-20200023046-A1 Oral composition and methods for immunotherapy Pending 13-Jun-2014 A61K39/0011
To view Immunitor’s complete patent history, request access »

Immunitor Executive Team (1)

Name Title Board Seat Contact Info
Aldar Bourinbaiar Chief Executive Officer & Principal
To view Immunitor’s complete executive team members history, request access »